Home

BIO Investor Forum Digital | October 13-15, 2020

Speakers & Presenters

Below is the current list of confirmed speakers and presenters for the 2020 BIO Investor Forum Digital. More speakers will be added in the lead up to the event, so check back regularly for updates.

Featured Speakers

Patrizia Cavazzoni, MD

DEPUTY DIRECTOR FOR OPERATIONS, FDA’S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)

Patrizia Cavazzoni, M.D., is the Deputy Director for Operations at FDA’s Center for Drug Evaluation and Research (CDER). In this position, Dr…

Cartier Esham, PhD

EXECUTIVE VICE PRESIDENT FOR EMERGING COMPANIES , BIOTECHNOLOGY INNOVATION ORGANIZATION

Cartier Esham serves as Executive Vice President for Emerging Companies at the Biotechnology Innovation Organization (BIO). In this role, Dr. Esham…

Jung-Chi Liao

FOUNDER, SYNCELL

Founder, SYNCELL INC. 2020- Research Fellow, 2019-present, Academia Sinica Associate Research Fellow, 2014-2019, Academia Sinica Assistant…

All Speakers

By Count | Alphabetical

Show All

Company Type

Show All

Main Therapeutic Focus

Show All

Development Phase of Primary Product

Show All

Search Speakers

Speaker Name

Country

Company

All Speakers

Filter by letter

Anne-Marie Carbonell, MD

CO-FOUNDER & CEO, ONCOSYNERGY, INC.

OncoSynergy, Inc

Greenwich, Connecticut, United States

Will Chou

CEO, ARUVANT SCIENCES, INC.

Aruvant

New York, New York, United States

Denis Dufrane, PHD, MD

CEO & FOUNDER, NOVADIP BIOSCIENCES SA

NOVADIP Biosciences sa

Mont-Saint-Guibert, Belgium

Lynn Durham

CEO & FOUNDER, STALICLA S.A.

STALICLA S.A.

Geneva, Switzerland

Charles Fisher

FOUNDER AND CEO , UNLEARN.AI

Unlearn.AI

San Francisco, California, United States

Yue Liu

PRESIDENT, AB STUDIO, INC.

Ab Studio, Inc.

Hayward, California, United States

Wang Yip Darren Lui, CFA, CA, BSC

PRESIDENT AND EXECUTIVE DIRECTOR, APTORUM GROUP LTD.

Aptorum Group Limited

London, United Kingdom

Sabrina Martucci Johnson

PRESIDENT & CEO, DARé BIOSCIENCE

Daré Bioscience

San Diego, California, United States

Shruti Abbato

EVP, BUSINESS DEVELOPMENT, MAXCYTE, INC.

CARMA Cell Therapies

Gaithersburg, Maryland, United States

Joe Abdo II, PHD, MS

CHIEF EXECUTIVE OFFICER, STELLA DIAGNOSTICS, INC.

Stella Diagnostics, Inc.

New York, New York, United States

Mert Aktar

VICE PRESIDENT AND HEAD OF CORPORATE DEVELOPMENT, KITE (A GILEAD COMPANY)

Fireside Chat: How the Kite Team is Fighting Cancer During a Pandemic

Brad Amendt

OWNER AND CSO, NATUREMIRI, LLC

NaturemiRI, LLC

Iowa City, Iowa, United States

Susan M. Angele

SENIOR ADVISOR, BOARD LEADERSHIP CENTER, KPMG

Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices

James Antonopoulos, JD

MANAGING DIRECTOR, CO-HEAD OF HEALTHCARE INVESTMENT BANKING, ROTH CAPITAL PARTNERS, LLC

Fireside Chat: Nisa Leung, Qiming Venture Partners and James Antonopoulos, ROTH Capital Partners on Cross-Pacific Investment Perspectives

New York, New York, United States

Robert Arathoon, PHD

FOUNDER AND CHIEF EXECUTIVE OFFICER, KENJOCKETY BIOTECHNOLOGY, INC

Kenjockety Biotechnology, Inc

South San Francisco, California, United States

Jan Aronsen

DR., SPARK JAN ARONSEN

SPARK Jan Aronsen

Oslo, Norway

Phyllis Arthur

VICE PRESIDENT, INFECTIOUS DISEASES & DIAGNOSTICS POLICY, BIO

Treating Infectious Diseases: Lessons from COVID-19 and Avoiding Future Pandemics

sundaresh babu, MESC

CSO, THERAINDX LIFESCIENCES PVT LTD

OncodynamiX Lifesciences pvt ltd

Bengaluru, Karnataka, India

Cheryl Baker, PhD

SCIENTIFIC CO-FOUNDER, DIRECTOR, BIOCURITY PHARMACEUTICALS INC.

BioCurity Pharmaceuticals Inc.

Jupiter, Florida, United States

Jonathan Baker, PHD

SENIOR TECHNOLOGY MANAGER, MONTANA BIOSCIENCE ALLIANCE

TechLink/Department of Veterans Affairs/Department of Defense

Bozeman, Montana, United States

Jianxin Bao, PHD

CEO, GATEWAY BIOTECHNOLOGY INC.

Gateway Biotechnology

Saint Louis, Missouri, United States

Dror Bashan

PRESIDENT & CEO, PROTALIX BIOTHERAPEUTICS

Protalix BioTherapeutics

Karmiel, Israel

Piraye Beim, PHD

CHIEF EXECUTIVE OFFICER, CELMATIX, INC.

Celmatix

New York, New York, United States

Abhijit Bhatia, MBA, MS

VICE PRESIDENT OF GLOBAL CORPORATE & BUSINESS DEVELOPMENT, RAKUTEN MEDICAL JAPAN K.K.

Rakuten Medical

San Diego, California, United States

Igor Bilinsky, PHD

CHIEF BUSINESS OFFICER, ONCTERNAL THERAPEUTICS

Oncternal Therapeutics

San Diego, California, United States

Greg Bosch, MBA

CHIEF EXECUTIVE OFFICER, GEISTLICH PHARMA NORTH AMERICA, INC

Geistlich Pharma

Princeton, New Jersey, United States

Martin Bott

GENERAL MANAGER (INTERIM), THE AMR ACTION FUND

The New AMR Action Fund to Invest in Antibiotic Development

Janice Bourque

MANAGING DIRECTOR, LIFE SCIENCES, HERCULES CAPITAL

Market Outlook: Solid Ground or Thin Ice?

Melissa Bradford-Klug

CHIEF BUSINESS OFFICER, CITRINE MEDICINE

China Deal-Making Now: New Opportunities and Barriers

Cambridge, Massachusetts, United States

Ross Breckenridge, PHD, MD

CEO, ARJUNA THERAPEUTICS

ARJUNA Therapeutics

Santiago de Compostela, Spain

Charles "Chuck" Calderaro

SENIOR VICE PRESIDENT AND GLOBAL HEAD OF TECHNICAL OPERATIONS, KITE (A GILEAD COMPANY)

Fireside Chat: How the Kite Team is Fighting Cancer During a Pandemic

Diana Caldwell

CEO AND PRESIDENT, AMPLIFIED SCIENCES, LLC

Amplified Sciences

West Lafayette, Indiana, United States

Ray Camphausen

CEO, WAYLAND BIOTHERAPEUTICS, LLC

Wayland Biotherapeutics LLC

WAYLAND, Massachusetts, United States

Anne-Marie Carbonell, MD

CO-FOUNDER AND CEO, ONCOSYNERGY

Trends in New Oncology Target Treatments (KRAS, MET, STING, and Beyond)

Patrizia Cavazzoni, MD

DEPUTY DIRECTOR FOR OPERATIONS, FDA’S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)

Fireside Chat: Patrizia Cavazzoni, MD, Deputy Director for Operations, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA)

Howard Chen

MANAGING PRINCIPAL, MANAGEMENT CONSULTING, IQVIA CHINA

China Deal-Making Now: New Opportunities and Barriers

Jung E. Choi

CHIEF BUSINESS & STRATEGY OFFICER, GLOBAL BLOOD THERAPEUTICS

Addressing Racism and Disparities during Therapeutic Development and in the Clinic

Guy Cipriani

CBO, MICROBION CORPORATION

Microbion Corporation

Bozeman, Montana, United States

Christopher Clegg

PRESIDENT, TRIA BIOSCIENCE

TRIA Bioscience

Seattle, Washington, United States

Matt Coffey

CEO, ONCOLYTICS BIOTECH

Oncolytics Biotech

Calgary, Alberta, Canada

Grace Colon, PHD

PRESIDENT & CEO, INCARDA THERAPEUTICS INC.

Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices

Newark, California, United States

Kevin Conroy, JD

PRESIDENT AND CEO, EXACT SCIENCES CORPORATION

New Directions in Diagnostics Innovation

Madison, Wisconsin, United States

Tyler Cook

CHIEF FINANCIAL OFFICER, SAMUS THERAPEUTICS, INC.

Samus Therapeutics

Topsfield, Massachusetts, United States

Helena Cowley, MBA, MS

CEO, OXIDIEN PHARMACEUTICALS, LLC

Oxidien Pharmaceuticals

Gainesville, Florida, United States

William Crossman

PRESIDENT & CEO, PHOENIX PHARMALABS, INC

Phoenix PharmaLabs, Inc.

Woods Cross, Utah, United States

Max Cynader

CEO, PRIMARY PEPTIDES INC

Primary Peptides Inc

Vancouver, British Columbia, Canada

Atul Deshpande, PHD, MBA, PMP

CHIEF STRATEGY OFFICER AND HEAD, US OPERATIONS, HARBOUR BIOMED

Harbour BioMed

Cambridge, Massachusetts, United States

Brett Dines

CEO, OYE THERAPEUTICS, INC

OYE Therapeutics, Inc

Crown Point, Indiana, United States

Daniel Dornbusch, MBA, MPH

CHIEF EXECUTIVE OFFICER, EXCISION BIOTHERAPEUTICS

Excision BioTherapeutics

Oakland, California, United States

Mark Emalfarb

CHIEF EXECUTIVE OFFICER, DYADIC INTERNATIONAL, INC

Dyadic International, Inc.

Jupiter, Florida, United States

Steven Engle

CEO, COHBAR INC.

CohBar, Inc.

Menlo Park, California, United States

Timothy Enns

PRESIDENT & CEO, NANOVALENT PHARMACEUTICALS, INC

NanoValent Pharmaceuticals Inc

Pleasanton, California, United States

Anna Eriksrud

CEO, NEODYNAMICS AB

NeoDynamics AB (publ)

Lidingo, Stockholm, Sweden

Cartier Esham, PhD

EXECUTIVE VICE PRESIDENT FOR EMERGING COMPANIES , BIOTECHNOLOGY INNOVATION ORGANIZATION

Fireside Chat: Patrizia Cavazzoni, MD, Deputy Director for Operations, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA)

Washington, District Of Columbia, United States

Joseph Evans, PHD

CEO & PRESIDENT, PLEIOGENIX

Pleiogenix

Carlsbad, California, United States

Robert Fallon

PRESIDENT & CEO, PHOSPLATIN THERAPEUTICS

Phosplatin Therapeutics

New York, New York, United States

Peter Fedichev, PhD

CEO, GERO

Gero

Singapore, Singapore

Justin Field

SVP, GOVERNMENT AFFAIRS, NVCA

U.S. Election Outlook: Presidential & Congressional Scenario Planning for Biopharma Priorities

Gregory Frank, PhD

SENIOR DIRECTOR, INFECTIOUS DISEASE POLICY, BIO

The New AMR Action Fund to Invest in Antibiotic Development

Steven Fruchtman, MD

PRESIDENT & CEO, ONCONOVA THERAPEUTICS, INC.

Onconova Therapeutics, Inc.

Newtown, Pennsylvania, United States

Tim Gallagher

CHIEF BUSINESS OFFICER, PHOSPHOGAM

PhosphoGam

Cary, North Carolina, United States

Jeffrey Galvin

CHIEF EXECUTIVE OFFICER, AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.

American Gene Technologies

Rockville, Maryland, United States

Ricardo Garcia

CEO | FOUNDER, ONCOHEROES BIOSCIENCIES INC.

Oncoheroes Biosciences Inc.

Brookline, Massachusetts, United States

Julie L. Gerberding

CHIEF PATIENT OFFICER AND EXECUTIVE VICE PRESIDENT, MERCK

Treating Infectious Diseases: Lessons from COVID-19 and Avoiding Future Pandemics

Geno Germano

PRESIDENT & CHIEF EXECUTIVE OFFICER, ELUCIDA ONCOLOGY, INC

Elucida Oncology

Monmouth Junction, New Jersey, United States

Simba Gill

VENTURE PARTNER;PRESIDENT AND CEO, FLAGSHIP PIONEERING;EVELO

Treating Infectious Diseases: Lessons from COVID-19 and Avoiding Future Pandemics

Roberta Gioia

CEO, GENECHRON SRL

Genechron Srl

Rome, Italy

L. Michael Glodé

PRESIDENT, AURORA ONCOLOGY

Aurora Oncology

Golden, Colorado, United States

Guy Goldberg

CHIEF BUSINESS OFFICER, REDHILL BIOPHARMA

RedHill Biopharma

Raleigh, North Carolina, United States

Manijeh Goldberg, PHD

CEO, PRIVO TECHNOLOGIES

Privo Technologies Inc

Peabody, Massachusetts, United States

Asthika Goonewardene

MANAGING DIRECTOR, EQUITY RESEARCH ANALYST – BIOTECH, TRUIST SECURITIES

Trends in New Oncology Target Treatments (KRAS, MET, STING, and Beyond)

Carla Grandori, PHD, MD

CO-FOUNDER AND CEO, SENGINE PRECISION MEDICINE

SEngine Precision Medicine

Seattle, Washington, United States

Jackie Grant, PhD

PRINCIPAL, ABINGWORTH

Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices

Irene Griswold-Prenner, PHD

CHIEF EXECUTIVE OFFICER & CSO, NITROME BIOSCIENCES, INC.

How to Pivot Neurodegeneration Treatment Research?

Brisbane, California, United States

Gunnveig Grodeland, PHD, MSC

DR., UNIVERSITY OF OSLO

SPARK Norway

Oslo, Norway

Jonas Grossman

PARTNER AND PRESIDENT, CHARDAN

SPACs: Advantages and Disadvantages Versus Normal IPO

Al Guillem

CEO, ONCONANO MEDICINE, INC.

OncoNano Medicine, Inc.

Southlake, Texas, United States

Sonia Gupta

MANAGING DIRECTOR, INVESTMENT BANKING DIVISION, GOLDMAN SACHS & CO. LLC

Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices

Sean Hall, MD

CEO, MEDLAB

Medlab Clinical Limited

Sydney, New South Wales, Australia

Dror Harats, MD

CHIEF EXECUTIVE OFFICER, VASCULAR BIOGENICS LTD.

Vascular Biogenics Ltd

Modi'in, Israel

Jay Heller

VP, HEAD OF CAPITAL MARKETS, NASDAQ

SPACs: Advantages and Disadvantages Versus Normal IPO

Patrick Hines, MD, PhD

FOUNDER & CEO, FUNCTIONAL FLUIDICS

Functional Fluidics

Detroit, Michigan, United States

Carole Ho, MD

CHIEF MEDICAL OFFICER, DENALI THERAPEUTICS INC.

How to Pivot Neurodegeneration Treatment Research?

South San Francisco, California, United States

KEN HORNE

PRESIDENT & COO, TEON THERAPEUTICS, INC.

Teon Therapeutics, Inc.

Redwood City, California, United States

Thomas Hudson, MD

SENIOR VICE PRESIDENT, RESEARCH AND DEVELOPMENT AND CHIEF SCIENTIFIC OFFICER, ABBVIE

Trends in New Oncology Target Treatments (KRAS, MET, STING, and Beyond)

Brady Huggett

BUSINESS EDITOR, NATURE BIOTECHNOLOGY

Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices

Tom Isett

CEO, IBIO, INC.

iBio, Inc.

New York, New York, United States

Tero Jarvinen

PROFESSOR, TAMPERE UNIVERSITY

SPARK Finland DecoDerma

Tampere, Finland

Alexis Ji

PARTNER, ILLUMINA VENTURES

New Directions in Diagnostics Innovation

Foster City, California, United States

Patrick Jordan, MBA, MA

CEO, MYCOVIA PHARMACEUTICALS, INC.

Mycovia Pharmaceuticals

Durham, North Carolina, United States

Maha Katabi

GENERAL PARTNER, SOFINNOVA

Market Outlook: Solid Ground or Thin Ice?

Syed Kazmi, PHD, MBA

PRESIDENT & CHIEF EXECUTIVE OFFICER, JUBILANT THERAPEUTICS, INC.

Jubilant Therapeutics Inc

Bedminster, New Jersey, United States

Lawrence Kenyon

PRESIDENT, CEO AND CFO, OUTLOOK THERAPEUTICS

Outlook Therapeutics, Inc.

East Windsor, New Jersey, United States

Rachel King

FOUNDER & CEO, GLYCOMIMETICS, INC.

U.S. Election Outlook: Presidential & Congressional Scenario Planning for Biopharma Priorities

Rockville, Maryland, United States

Michael Kokesh

PRESIDENT & CEO, VICARDIA THERAPEUTICS, INC.

ViCardia Therapeutics, Inc.

San Francisco, California, United States

Pat Lawman, PHD

CEO, MORPHOGENESIS INC.

Morphogenesis, Inc.

Tampa, Florida, United States

Seth Lederman, MD

CHIEF EXECUTIVE OFFICER, TONIX PHARMACEUTICALS, INC

Tonix Pharmaceuticals Holding Corp.

New York, New York, United States

David Lederman

DIRECTOR, EQUITY CAPITAL MARKETS, CHARDAN

Market Outlook: Solid Ground or Thin Ice?

Nisa Leung

MANAGING PARTNER, QIMING VENTURE PARTNERS

Fireside Chat: Nisa Leung, Qiming Venture Partners and James Antonopoulos, ROTH Capital Partners on Cross-Pacific Investment Perspectives

Hong Kong, Hong Kong

Jung-Chi Liao

FOUNDER, SYNCELL

SYNCELL INC.

Taipei, Taiwan

Mike Liccardo

VP CORP DEV. & CFO, INVESTOR, PARTNER WITH STRAWBERRY CREEK VENTURES, SHAREVAULT

ShareVault

Los Gatos, California, United States

Pedro Lichtinger, MBA

CHAIRMAN & CEO, STARTON THERAPEUTICS

Starton Therapeutics

Paramus, New Jersey, United States

Matt Liddelow, PHARMD, BSC

CEO & MANAGING DIRECTOR, NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

NeuroScientific Biopharmaceuticals Ltd

Nedlands, Western Australia, Australia

Jeff Living, PhD

CHIEF EXECUTIVE OFFICER, IGIA PHARMACEUTICALS

Igia Pharmaceuticals

Franklin, Massachusetts, United States

Thomas Loarie, MBA

CEO AND CO-FOUNDER, BRYOLOGYX INC.

BryoLogyx Inc.

Danville, California, United States

Maria Maccecchini, PHD

PRESIDENT & CEO, ANNOVIS BIO, INC.

Annovis Bio, Inc.

Berwyn, Pennsylvania, United States

David Mann

CEO, VASCULAR BIOSCIENCES, INC.

Vascular BioSciences

Goleta, California, United States

Dave Mantus

PRESIDENT US OPERATIONS, PULMOCIDE

Pulmocide

Boston , Massachusetts, United States

Trevor Martin, PhD

CO-FOUNDER AND CEO, MAMMOTH BIOSCIENCES

New Directions in Diagnostics Innovation

Shinichi Matsumoto, PHD, MD

CHIEF SCIENTIFIC ADVISOR, OTSUKA PHARMACEUTICAL FACTORY, INC.

Otsuka Pharmaceutical Factory, Inc.

Kobe, Japan

Glenn Mattes

PRESIDENT, CHIEF EXECUTIVE OFFICER AND DIRECTOR, TFF PHARMA

TFF Pharmaceuticals, Inc.

Austin, Texas, United States

Mike Mattoon

VICE PRESIDENT, FEDERAL GOVERNMENT RELATIONS, BIO

U.S. Election Outlook: Presidential & Congressional Scenario Planning for Biopharma Priorities

David Mazzo, PHD

PRESIDENT & CEO, CALADRIUS BIOSCIENCES, INC

Caladrius Biosciences, Inc.

Basking Ridge, New Jersey, United States

Joe McCann

CEO, POINT BIOPHARMA

POINT Biopharma

Toronto, Ontario, Canada

Michelle McMurry-Heath, MD, PhD

PRESIDENT & CEO, BIO

Addressing Racism and Disparities during Therapeutic Development and in the Clinic

Raj Mehra

CEO, SEELOS THERAPEUTICS

Seelos Therapeutics

New York, New York, United States

Sara Michelmore

SENIOR VICE PRESIDENT, INVESTOR RELATIONS, MACDOUGALL

Market Outlook: Solid Ground or Thin Ice?

Steve Miller, MD

EXECUTIVE VICE PRESIDENT & CHIEF CLINICAL OFFICER, CIGNA CORPORATION

New Directions in Diagnostics Innovation

Frank Minella

CEO, PAINQX

PainQx

New York, New York, United States

James Moe, PHD, MBA

PRESIDENT, OLIGOMERIX, INC.

Oligomerix, Inc.

Bronx, New York, United States

Katherine Moortgat

VENTURES, ABBVIE INC.

How to Pivot Neurodegeneration Treatment Research?

North Chicago, Illinois, United States

Adi Mor, PHD

CO-FOUNDER AND CEO, CHEMOAMB

Chemomab

Tel Aviv, Israel

Christopher Myatt, PHD

CEO, MBIO DIAGNOSTICS, INC

MBio Diagnostics | LightDeck

Boulder, Colorado, United States

Reto Naef, PHD

CEO, TOPADUR PHARMA AG

Topadur Pharma AG

Schlieren, Zurich, Switzerland

Sonja Nesbit

MANAGING DIRECTOR GOVERNMENT AFFAIRS, FTI CONSULTING

U.S. Election Outlook: Presidential & Congressional Scenario Planning for Biopharma Priorities

Carolyn Ng, PhD

MANAGING DIRECTOR, VERTEX VENTURES HC

Trends in New Oncology Target Treatments (KRAS, MET, STING, and Beyond)

Daniel O'Connell

PRESIDENT & CEO, ACUMEN PHARMACEUTICALS, INC

Acumen Pharmaceuticals, Inc.

Charlottesville, Virginia, United States

Tim Oldham, PHD

CEO AND MANAGING DIRECTOR, ADALTA PTY LTD.

AdAlta Ltd

Bundoora, Victoria, Australia

Frederic Ors

CFO, IMV INC.

IMV Inc.

Dartmouth, Nova Scotia, Canada

Won Park

PROFESSOR, SPARK/COLORADO/PARKFLAIG

SPARK/COLORADO/ParkFlaig

Boulder, Colorado, United States

Han-Oh Park

CEO, SIRNAGEN THERAPEUTICS

siRNAgen.therapeutics

Daejeon, Korea - South Korea

Francis Parnell, MD

CHAIRMAN & CEO, PARNELL PHARMACEUTICALS, INC.

Parnell Pharmaceuticals, Inc.

San Rafael, California, United States

Snehal Patel

CHIEF EXECUTIVE OFFICER, GREENWICH LIFESCIENCES

Greenwich LifeSciences

Sugar Land, Texas, United States

Brian Patrick, MBA

PRESIDENT, A2 THERAPEUTICS

A2 Therapeutics

Houston, Texas, United States

Preethy Paul, PHD

PROJECT MANAGER, SPARK PREETHY PAUL

SPARK Preethy Paul

Turku, Finland

Cindy Perettie

CHIEF EXECUTIVE OFFICER, FOUNDATION MEDICINE, INC

New Directions in Diagnostics Innovation

Cambridge, Massachusetts, United States

Andrea Pfeifer, PhD

CHIEF EXECUTIVE OFFICER, AC IMMUNE

How to Pivot Neurodegeneration Treatment Research?

Jonathan Polak

CHIEF EXECUTIVE, MESENTECH INC.

Mesentech

Vancouver, British Columbia, Canada

Alexander Polinsky, PHD

CHIEF EXECUTIVE OFFICER, ONCOTARTIS, INC.

OncoTartis, Inc.

Buffalo, New York, United States

Konstantin Poukalov

MANAGING DIRECTOR, PERCEPTIVE ADVISORS, LLC

China Deal-Making Now: New Opportunities and Barriers

New York, New York, United States

Ferran Prat, PHD, JD

VP OF STRATEGIC INDUSTRY VENTURES, UNIVERSITY OF TEXAS, MD ANDERSON CANCER CENTER

Trends in New Oncology Target Treatments (KRAS, MET, STING, and Beyond)

Houston, Texas, United States

Karthik Ramachandran, PHD

VP & FOUNDER, LIKARDA, LLC

Likarda, LLC

Kansas City, Missouri, United States

Natarajan Ranganathan, PHD

MANAGING DIRECTOR, KIBOW BIOTECH, INC

Kibow Biotech, Inc.

Newtown Square, Pennsylvania, United States

Jeanne M. Regnante

CHIEF HEALTH EQUITY AND DIVERSITY OFFICER, LUNGEVITY

Addressing Racism and Disparities during Therapeutic Development and in the Clinic

Brian Rye

SENIOR HEALTHCARE POLICY ANALYST , BLOOMBERG INTELLIGENCE

U.S. Election Outlook: Presidential & Congressional Scenario Planning for Biopharma Priorities

Jordan B. Saxe

SENIOR MANAGING DIRECTOR, LISTING SERVICES, NASDAQ

Market Outlook: Solid Ground or Thin Ice?

Christopher Schaber, PHD

PRESIDENT & CEO, SOLIGENIX, INC.

Soligenix, Inc.

Princeton, New Jersey, United States

Chris Schelling

CEO AND FOUNDER, ACER THERAPEUTICS INC.

Acer Therapeutics

Newton, Massachusetts, United States

Andrew J. Schwab

FOUNDER AND MANAGING PARTNER, 5AM VENTURES

Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices

Panna Sharma

CEO, PRESIDENT AND DIRECTOR, LANTERN PHARMA

Lantern Pharma

Christi Shaw

CHIEF EXECUTIVE OFFICER, KITE (A GILEAD COMPANY)

Fireside Chat: How the Kite Team is Fighting Cancer During a Pandemic

Kira Sheinerman

CEO, DIAMIR, LLC

DiamiR

Monmouth Junction, New Jersey, United States

Craig Shimasaki

CO-FOUNDER & CEO, MOLECULERA LABS

Moleculera Labs

Oklahoma City, Oklahoma, United States

Scott Shively

CHIEF EXECUTIVE OFFICER, NEUMENTUM, INC.

Neumentum, Inc.

Morristown, New Jersey, United States

Sanjay Shukla, MD, MS

PRESIDENT, CEO, ATYR PHARMA, INC.

aTyr Pharma

San Diego, California, United States

George Simeon

CHIEF EXECUTIVE OFFICER, CUREVO, INC.

Curevo Vaccine Inc.

Seattle, Washington, United States

Shawn Singh

CHIEF EXECUTIVE OFFICER, VISTAGEN THERAPEUTICS, INC.

VistaGen Therapeutics, Inc.

South San Francisco, California, United States

Mark Sirgo, PHARMD

CHIEF EXECUTIVE OFFICER, ARUNA BIO

Aruna Bio, Inc.

Athens, Georgia, United States

Yochi Slonim

CO-FOUNDER AND CEO, ANIMA BIOTECH INC.

Anima Biotech Inc

Bernardsville, New Jersey, United States

Srinivas Sridhar, PHD

DIRECTOR, THERANANO LLC

Theranano LLC

Newton Center, Massachusetts, United States

Otello Stampacchia , PhD

MANAGING DIRECTOR, OMEGA FUNDS

Treating Infectious Diseases: Lessons from COVID-19 and Avoiding Future Pandemics

David Stover

CSO, QWIXEL THERAPEUTICS, LLC

Qwixel Therapeutics LLC

Los Angeles, California, United States

Shehnaaz Suliman, MD, MBA, MPhil

PRESIDENT AND CHIEF OPERATING OFFICER, ALECTOR, INC.

How to Pivot Neurodegeneration Treatment Research?

Cathy Swindlehurst, PHD

CEO, NOVOMEDIX, LLC

NovoMedix, LLC

San Diego, California, United States

Marco Taglietti, MD

PRESIDENT & CHIEF EXECUTIVE OFFICER, SCYNEXIS, INC.

SCYNEXIS, Inc.

Jersey City, New Jersey, United States

Ken Takeshita, MD

SENIOR VICE PRESIDENT AND GLOBAL HEAD OF CLINICAL DEVELOPMENT, KITE (A GILEAD COMPANY)

Fireside Chat: How the Kite Team is Fighting Cancer During a Pandemic

Robert Tarran

FOUNDER/CSO, ELDEC PHARMACEUTICALS

Eldec Pharmaceuticals

Chapel Hill, North Carolina, United States

John Temperato

PRESIDENT & CEO, 9 METERS BIOPHARMA, INC.

9 Meters Biopharma, Inc.

Raleigh, North Carolina, United States

Daniel Teper, MBA, PHARMD

CHAIRMAN & CEO, CYTOVIA THERAPEUTICS, INC.

Cytovia Therapeutics

New York, New York, United States

Nikolaos Tezapsidis, PHD

PRESIDENT & CEO, NEUROTEZ, INC.

Neurotez Inc.

BRIDGEWATER, New Jersey, United States

Brian Toglia

LIFE SCIENCE PRACTICE LEADER, HIGGINBOTHAM

Higginbotham

Houston, Texas, United States

Martin Tolar

FOUNDER AND CEO, ALZHEON, INC.

How to Pivot Neurodegeneration Treatment Research?

Framingham, Massachusetts, United States

Philip Toleikis

PRESIDENT AND CEO, SERNOVA CORP.

Sernova Corp.

London, Ontario, Canada

Pascal Touchon

PRESIDENT & CEO, ATARA BIOTHERAPEUTICS, INC.

Atara Biotherapeutics, Inc.

South San Francisco, California, United States

Vuong Trieu, PHD

CEO, ONCOTELIC, INC.

Mateon Therapeutics

Agoura Hills, California, United States

Andrea Wang

COFOUNDER AND CEO, AHEAD MEDICINE

AHEAD Medicine

Berkeley, California, United States

Zhirui Wang, PHD

PRESIDENT, ROCK IMMUNE LLC

SPARK Colorado-Rock Immune LLC

Denver, Colorado, United States

Yan Wang

PRESIDENT/CSO, GNOMEGEN

Gnomegen

San Diego, California, United States

Joshua Wang

FOUNDER/CSO, VERIMMUNE

VerImmune

Baltimore, Maryland, United States

Raymond Warrell Jr., MD

CEO, ACQUIST THERAPEUTICS, INC.

Acquist Therapeutics, Inc.

Chatham, New Jersey, United States

Ethan J. Weiss, MD

CARDIOLOGIST AND ASSOCIATE PROFESSOR, UCSF HEALTH

Treating Infectious Diseases: Lessons from COVID-19 and Avoiding Future Pandemics

Steve Welker

CHIEF BUSINESS DEVELOPMENT OFFICER, AAVOCYTE, INC.

Aavocyte, Inc.

Bellevue, Washington, United States

James West III, ACA, MS

CEO, CLARA BIOTECH

Clara Biotech, Inc.

Lawrence, Kansas, United States

Pierre Wijdenes

CEO, NEURAURA

Neuraura Biotech Inc.,

Calgary, Alberta, Canada

Blake Wise

CHIEF EXECUTIVE OFFICER, NOVOME BIOTECHNOLOGIES, INC.

Novome Biotechnologies

South San Francisco, California, United States

Rob Wright

CHIEF EDITOR, LIFE SCIENCE LEADER

Fireside Chat: How the Kite Team is Fighting Cancer During a Pandemic

Jinzi Wu, PHD

FOUNDER, CHAIRMAN AND CEO, ASCLETIS PHARMA INC.

China Deal-Making Now: New Opportunities and Barriers

Hangzhou, Zhejiang, China

Kikuo Yasui, MSC

COO, HEARTSEED

Heartseed Inc.

Tokyo, Japan

Gang Zeng, PHD

PRESIDENT AND CEO, T-CURE BIOSCIENCE INC.

T-Cure Bioscience

Sherman Oaks, California, United States

Debbie Zhuang

MANAGING DIRECTOR, CLEARVIEW HEALTHCARE PARTNERS

New Directions in Diagnostics Innovation

Stevin Zorn, PHD, MS, BS

PRESIDENT AND CEO, MIND IMMUNE

MindImmune Therapeutics Inc.

Salem, Connecticut, United States

Explore BIO

Policy

Events

Industry Insights

About

Join Now

For Members

Member Directory

BIO Policy Committees

Cost-Savings Program

BIO Events

BIO Digital

BIO CEO & Investor Conference

BIO Investor Forum Digital

BIO IMPACT Digital

BIO Online Learning

BIO DOUBLE HELIX SPONSORS

BIO HELIX SPONSORS

1201 Maryland Avenue SW, Suite 900, Washington, DC, 20024 ・ 202-962-9200

Contact BIO